Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey

被引:53
作者
Lamontagne, S
Meadows, E
Luk, P
Normandin, D
Muise, E
Boulet, L
Pon, DJ
Robichaud, A
Robertson, GS
Metters, KM
Nantel, F
机构
[1] Merck Frosst Ctr Therapeut Res, Dept Pharmacol, Pointe Claire, PQ H9R 4P8, Canada
[2] Dept Biochem & Mol Biol, Pointe Claire, PQ H9R 4P8, Canada
[3] Lab Anim Res, Pointe Claire, PQ H9R 4P8, Canada
关键词
immunohistochemistry; in situ hybridization; emesis; medulla; nodose ganglion;
D O I
10.1016/S0006-8993(01)03023-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pre-clinical and clinical studies are currently underway to evaluate the potential of phosphodiesterase-4 (PDE4) inhibitors for the treatment of chronic obstructive pulmonary disease and other inflammatory conditions of the airways. The most common side effect associated with this class of compounds is emesis. The squirrel monkey provides a model for evaluating the efficacy of PDE4 inhibitors and their emetic potential. The distribution of three PDE4 isoforms (A, C and D) has been investigated in the squirrel monkey medulla and nodose ganglion to determine which isoform(s) could be responsible for the emetic adverse effects. The distribution of PDE4 isoforms was delineated using immunohistochemistry with antibodies specific for PDE4A. PDE4C and PDE4D and by in situ hybridization with isoform-selective riboprobes. PDE4A was present in the medulla where expression was mostly restricted to glial cells and the vasculature. PDE4C was not detected in either the medulla or nodose ganglion. Finally, the PDE4D isoform was localized to neurons in the nodose ganglion and found through many structures of medulla including the area postrema, neurons of the nucleus tractus solitarius and locus coeruleus. These data are consistent with a role for PDE4D in the emetic response. (C) 2001 Elsevier Science BY All rights reserved.
引用
收藏
页码:84 / 96
页数:13
相关论文
共 38 条
[1]   Development of a recombinant cell-based system for the characterisation of phosphodiesterase 4 isoforms and evaluation of inhibitors [J].
Allen, RA ;
Merriman, MW ;
Perry, MJ ;
Owens, RJ .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (12) :1375-1382
[2]  
Barnette M S, 1999, Prog Drug Res, V53, P193
[3]   PREPARATION OF PEPTIDE-PROTEIN IMMUNOGENS USING N-SUCCINIMIDYL BROMOACETATE AS A HETEROBIFUNCTIONAL CROSS-LINKING REAGENT [J].
BERNATOWICZ, MS ;
MATSUEDA, GR .
ANALYTICAL BIOCHEMISTRY, 1986, 155 (01) :95-102
[4]   DIFFERENTIAL CNS EXPRESSION OF ALTERNATIVE MESSENGER-RNA ISOFORMS OF THE MAMMALIAN GENES ENCODING CAMP-SPECIFIC PHOSPHODIESTERASES [J].
BOLGER, GB ;
RODGERS, L ;
RIGGS, M .
GENE, 1994, 149 (02) :237-244
[5]   EFFECT OF ABLATION OF AREA POSTREMA ON FREQUENCY AND LATENCY OF MOTION SICKNESS-INDUCED EMESIS IN THE SQUIRREL-MONKEY [J].
BRIZZEE, KR ;
ORDY, JM ;
MEHLER, WR .
PHYSIOLOGY & BEHAVIOR, 1980, 24 (05) :849-853
[6]  
Burns F, 1996, Adv Pharmacol, V36, P29, DOI 10.1016/S1054-3589(08)60575-X
[7]  
Cherry JA, 1999, J COMP NEUROL, V407, P287
[8]   A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo [J].
Cooper, N ;
Teixeira, MM ;
Warneck, J ;
Miotla, JM ;
Wills, RE ;
Macari, DMT ;
Gristwood, RW ;
Hellewell, PG .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (08) :1863-1871
[9]   Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents [J].
Doherty, AM .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) :466-473
[10]   Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain [J].
Farooqui, SM ;
Zhang, KH ;
Makhay, M ;
Jackson, K ;
Farooqui, SQ ;
Cherry, JA ;
O'Donnell, JM .
BRAIN RESEARCH, 2000, 867 (1-2) :52-61